
Global transmucosal drugs market to be valued at $28b by 2032
Thanks to the rising prevalence of chronic conditions.
The global transmucosal drugs market is projected to reach $28b by 2032 at a compound annual growth rate of 7%, said DelveInsight.
The sector’s expansion is attributed to the rising prevalence of chronic conditions like cardiovascular disease.
Meanwhile, increasing adoption of these drugs, research and development efforts, and collaborations amongst major industry players are driving market growth.
“Innovations such as nanoparticles, liposomes, and microneedles are improving the efficiency and accuracy of drug delivery systems,” the report said.